$199.00
Manufacturer: Germany
Purpose: Regulates blood sugar levels in diabetes by mimicking natural insulin.
Description
Lantus Solostar Solution for Injections 100 IU/ml. 3 ml. №5 Cartridge
Ingredients:
Lantus Solostar contains insulin glargine, glycerol, meta-cresol, zinc oxide, and water for injections.
Dosage:
The usual starting dose of Lantus Solostar is 10 units once daily. Dosage adjustments may be needed based on individual patient requirements.
Indications:
Lantus Solostar is indicated for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and above. It helps control blood sugar levels over an extended period.
Contraindications:
Do not use Lantus Solostar if you are allergic to insulin glargine or any of the other ingredients. It is not recommended for the treatment of diabetic ketoacidosis.
Directions:
Administer Lantus Solostar subcutaneously once daily at the same time each day. Rotate injection sites to prevent lipodystrophy.
Scientific Evidence:
Lantus Solostar has been extensively studied in clinical trials to establish its efficacy and safety profile. Research published in the Journal of Diabetes Science and Technology demonstrated that Lantus Solostar provided effective glycemic control in patients with type 2 diabetes, leading to improved long-term outcomes.
Additional Information:
In comparative studies, Lantus Solostar has shown comparable effectiveness to other long-acting insulin analogs in controlling blood glucose levels and reducing the risk of hypoglycemia. It offers a convenient once-daily dosing regimen, enhancing patient adherence to treatment.
Pharmacological Effects: Insulin glargine, the active ingredient in Lantus Solostar, acts by lowering blood glucose levels through enhanced cellular uptake of glucose and inhibition of hepatic glucose production. Its prolonged duration of action provides a steady release of insulin, mimicking the basal insulin secretion of the pancreas.
Clinical Trials: Clinical trials have shown that Lantus Solostar effectively reduces HbA1c levels, fasting plasma glucose, and postprandial glucose excursions in patients with diabetes. Long-term studies have demonstrated its role in preventing diabetes-related complications and improving overall quality of life for patients.
Recent Reviews